Emisphere Technologies And Alchemia To Research An Oral Formulation Of Fondaparinux With Eligen Technology
Source: Medical News Today
Sunday 21st March, 2010
0 posts Emisphere Technologies, Inc. (OTCBB:EMIS) and Alchemia Ltd. (ASX:ACL) announced that they are joining efforts to develop an oral formulation of the anti-coagulant drug fondaparinux with Emisph... ...
Read the full story at
Medical News Today
Email this story to a friend
Have your say on this story
